Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01148940 · ClinicalTrials.gov registry record
Sickle Cell Trait and the Risk of Venous Thromboembolism
A clinical trial, sponsored by Albert Einstein College of Medicine.
- Terminated
- Registry status
- 34
- Enrollment target
NCT01148940 is a clinical trial that was terminated before completion, run by Albert Einstein College of Medicine. The registered enrollment target is 34 participants.
The verdict
NCT01148940 was terminated before completion, sponsored by Albert Einstein College of Medicine.
- TERMINATED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The purpose of this trial is to investigate D-Dimer levels, a surrogate marker of venous thromboembolism, in pregnant/postpartum white women as compared to pregnant/postpartum black women, and pregnant/postpartum women with sickle cell trait. The investigators will determine whether increased D-Dimer levels are reflected in a greater incidence of thrombosis in the postpartum patient, as well as the prevalence of symptomatic venous thrombosis in black patients as compared to pregnant white patients and women with sickle cell trait. The investigators will also investigate the effect of blood group on these parameters. If there is evidence that there is an increased risk of thrombosis in sickle cell trait, the investigators will plan a trial of prophylactic anticoagulation during the last trimester and the four weeks post partum for patients with sickle cell trait and compare this population to patients who do not receive prophylactic anticoagulation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01148940
The ClinicalTrials.gov registry entry for NCT01148940 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01148940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01148940 about?
NCT01148940 is a clinical study titled "Sickle Cell Trait and the Risk of Venous Thromboembolism". The purpose of this trial is to investigate D-Dimer levels, a surrogate marker of venous thromboembolism, in pregnant/postpartum white women as compared to pregnant/postpartum black women, and pregnant/postpartum women with sickle cell trait. The investigators will determine whether increased D-Dime...
What is the current status of trial NCT01148940?
This trial is currently terminated. The enrollment target is 34 participants. The study started on 2010-07. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT01148940?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.